Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.


SHAPE Society

  • Login to see the comments

  • Be the first to like this


  1. 1. Stefanadis C et al, J Am Col Cardiol 2001 April ΔΤ - Percutanenous Coronary InterventionsΔΤ - Percutanenous Coronary Interventions
  2. 2. Coronary Thermography • Thermal heterogeneity exists in vivo in atherosclerotic plaque • Statins decrease thermal heterogeneity possibly by anti-inflammatory mechanism • Thermal heterogeneity in the culprit lesion is a prognostic factor for adverse cardiac events after percutaneous interventions • Is thermal heterogeneity a sensitive marker for future cardiac events?
  3. 3. Primary end point: Death, MI, TLR in 12 months Secondary end points: -Procedural complications -Cost effectiveness over 12 months Stenting of culprit lesion only Stenting of culprit + non-culprit lesions Randomization Non-culprit lesion(s) with > 0.10O C ∆T Patients with ACS and multivessel disease THERMO ACS: Culprit or Multivessel Revascularization based on Thermography in patients with ACS
  4. 4. …… Thermography Beyond Coronary ArteriesThermography Beyond Coronary Arteries